Maternal Smoking during Pregnancy and Changes in Prostaglandin Enzymes in the Human Fetus.

Aikaterini Zafeiri, Panagiotis Filis, Sophie Shaw, John P. Iredale, Madeleine J. Swortwood, Rod T. Mitchell, David C. Hay, Peter J. O'Shaughnessy, Paul A. Fowler

Research output: Contribution to journalAbstractpeer-review

Abstract

Introduction: Prostaglandins (PGs) are inflammatory modulators with important homeostatic and regenerative roles in the liver and their dysregulation can lead to pathological outcomes. Over 20% of pregnant women smoke and smoke constituents that reach the fetal liver can disrupt PG synthesis, contributing to negative outcomes for the offspring. In this study we examined the effect of maternal smoking on PG synthesis pathway in the human fetal liver.
Original languageEnglish
Article numberF-103
Pages (from-to)244A-244A
Number of pages1
JournalReproductive Sciences
Volume26
Issue numberSupplement 1
Early online date14 Feb 2019
DOIs
Publication statusPublished - 1 Mar 2019
Event66th Annual Scientific Meeting of the Society-for-Reproductive-Investigation (SRI) - Paris, France
Duration: 12 Mar 201916 Mar 2019

Fingerprint

Dive into the research topics of 'Maternal Smoking during Pregnancy and Changes in Prostaglandin Enzymes in the Human Fetus.'. Together they form a unique fingerprint.

Cite this